Kelly Beck

Kelly Beck is a seasoned executive and board member with extensive experience in the biopharmaceutical and human resources sectors. Currently serving as a Board Member and Compensation Committee Chair at Orphagen Pharmaceuticals since August 2024, and as Board Chair of the National Panhellenic Conference Inc. since July 2023, Beck advocates for the sorority experience and oversees governance for a significant women’s organization. Previously, Kelly held the position of Chief Executive Officer and Board Member at PolyCore Therapeutics, Inc., where strategic leadership efforts advanced the development of therapeutic solutions for Parkinson's Disease. Other notable roles include National President of Alpha Sigma Alpha Sorority and Vice President of Investor Relations at Ocugen. Throughout a distinguished career, Kelly has demonstrated expertise in governance, strategic planning, and human resources across various organizations. Educational qualifications include an MBA in Biotechnology and Health Industry Management and multiple degrees and certificates from prestigious institutions.